STEVENSON, Md., Sept. 12, 2016 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of purchasers of Warren Resources, Inc. (Other OTC:WRESQ) (“Warren” or the “Company”) common stock during the period between November 4, 2014 through June 2, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 11, 2016 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Warren common stock during the Class Period. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company was well positioned to handle the market conditions, when, in fact, the Company was becoming increasingly insolvent.
According to the complaint, following a June 2, 2016 filing of a voluntary petition for Chapter 11 bankruptcy, the value of Warren shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Warren common stock purchased on or after November 4, 2014 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 



